No profile data available.
Response Genetics, Inc (RGDXQ) is a healthcare company in the additional medical testing equipment industry, based in Los Angeles, United States, with about 96 full-time employees.
It reported revenue of $18.04 million for fiscal year 2015, up 76.9% from fiscal year 2014, and net income of -$20.18 million. In Q1 2015 (the quarter ended March 31, 2015) revenue was $3.79 million, down 2.7% from a year before. Its market capitalization was $1,365 as of October 8, 2026.
Figures from company filings and market data; latest fiscal year ended December 31, 2015; market data as of October 8, 2026.
, a life sciences company, researches, develops, markets, and sells pharmacogenomic tests for use in the treatment of cancer in the United States, Europe, and internationally. The company offers tests for measuring predictive factors for therapy response in tumor tissue samples.
Response Genetics reported $18.04 million in revenue for fiscal year 2015, up 76.9% from $10.20 million in fiscal year 2014. In Q1 2015 revenue was $3.79 million.
$1,365 as of October 8, 2026.
Listed companies of a similar size in the same industry (additional medical testing equipment) include Medical Imaging Corp. (MEDD), Cyclo3pss Corporation (CYPS), Integrative Health Technologies, Inc. (IHTI), Rosetta Genomics Ltd. (ROSGQ).